Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y | YTD ▼ | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Intra-Cellular Therapies Inc. | 4.310% | -1.218% | 1.323% | 65.090% | 20.683% | 348.001% | 404.299% |
| Supernus Pharmaceuticals | 2.740% | 7.914% | 11.111% | 17.188% | 11.111% | - | - |
| Pfizer Inc. | 1.250% | 6.191% | 3.683% | 55.836% | 1.668% | 39.385% | 87.942% |
| Intercept Pharmaceuticals | -10.260% | 14.931% | 7.253% | -6.944% | -0.596% | -79.234% | -86.217% |
| Clovis Oncology Inc. | -4.680% | 30.772% | 233.151% | -54.785% | -11.132% | -83.502% | -97.416% |
| Forte Biosciences Inc. | -3.070% | 1.365% | 2.268% | -95.426% | -30.632% | - | - |
| Ligand Pharmaceuticals | 1.810% | 10.826% | 20.837% | -13.517% | -34.438% | -7.503% | -10.168% |
| MorphoSys AG | 3.020% | 13.439% | 8.774% | -66.939% | -34.553% | -75.769% | -64.283% |
| Sartorius AG VZO | -0.490% | 14.053% | -0.296% | -20.219% | -37.956% | 106.860% | 317.117% |
| Cytomx Therapeutics Inc | -30.030% | 6.868% | 17.581% | -62.534% | -51.666% | - | - |
| Align Technology | -0.120% | 5.603% | -3.733% | -52.092% | -57.568% | -0.407% | 86.025% |
| Chimerix Inc. | -0.130% | 14.453% | 35.031% | -67.929% | -62.166% | -39.517% | -55.430% |
| Eckert & Ziegler Strahlen- und Medizintechnik AG | 2.320% | -4.215% | -17.170% | -65.563% | -63.430% | 34.922% | 286.103% |
| Benitec Biopharma Inc. | -0.340% | -35.733% | -9.938% | -75.371% | -64.517% | -92.933% | -96.554% |
| Athersys Inc. | -8.710% | -11.999% | 8.449% | -80.382% | -66.252% | -83.303% | -83.913% |
| Evofem Biosciences Inc. | 1.330% | 40.231% | 292.043% | -89.823% | -73.934% | - | - |
| Agile Therapeutics Inc. | 10.170% | -59.119% | -43.576% | -98.535% | -96.264% | - | - |
